Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Lilly reports cannabinoid receptor antagonists

April 19, 1996

Dolasetron submitted for approval in U.S.

April 19, 1996

Cerebyx approvable in USA

April 19, 1996

Myotrophin NDA submission on track

April 19, 1996

GP-3269, new AK inhibitor from Gensia

April 19, 1996

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

P&U's U-99363E shows high affinity for D4 receptors

April 19, 1996

BASF reports dopamine D3 ligands

April 19, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...